合成具有pH敏感性缓释偶联有透明质酸受体的甲氨蝶呤负载氟化铈纳米粒,其具有用于临床前安全性研究的合理治疗诊断能力
Synthesis of Methotrexate loaded Cerium fluoride nanoparticles with pH sensitive extended release coupled with Hyaluronic acid receptor with plausible theranostic capabilities for preclinical safety studies
摘要:
药物递送系统中的一个关键挑战是实时监测递送的药物和随后的响应。纳米技术的最新进展使得具有治疗诊断能力的新型药物递送系统(DDS)的设计和临床前实施成为可能。在此,荧光氟化铈(CeF 3)纳米粒子(nps)的合成和它们的表面修饰的聚乙烯亚胺(PEI)涂层。此后,通过戊二醛交联将甲氨蝶呤偶联在其上,用于pH敏感性释放。随后通过1-乙基-3-(3-二甲基氨基丙基)-碳二亚胺和N-羟基琥珀酰亚胺(EDC-NHS)化学添加透明质酸(HA)受体,以实现可能的活性药物靶向系统。所获得的药物递送纳米制剂保留并表现出归因于纳米颗粒的独特的光致发光性质,同时表现出潜在的治疗诊断能力。
英文摘要:
A key challenge in drug delivery systems is the real time monitoring of delivered drug and subsequent response. Recent advancement in nanotechnology has enabled the design and preclinical implementation of novel drug delivery systems (DDS) with theranostic abilities. Herein, fluorescent cerium fluoride (CeF3) nanoparticles (nps) were synthesized and their surface modified with a coat of polyethylenimine (PEI). Thereafter, Methotrexate was conjugated upon it through glutaraldehyde crosslinking for a pH-sensitive release. This was followed by the addition of a Hyaluronic acid (HA) receptor via 1-Ethyl-3-(3-dimethylaminopropyl)-carbodiimide and N-hydroxysuccinimide (EDC-NHS) chemistry to achieve a possible active drug targeting system. The obtained drug delivery nano-agent retains and exhibits unique photo-luminescent properties attributed to the nps while exhibiting potential theranostic capabilities.
机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。